The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease-Reference-Cited by-同舟云学术

The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease

Published:2023-10 Issue:10 Volume:29 Page:830-842
ISSN:1471-4914
Container-title:Trends in Molecular Medicine
language:en
Short-container-title:Trends in Molecular Medicine

Author:

Geertsema Sem,Bourgonje Arno R.^ORCID,Fagundes Raphael R.,Gacesa Ranko,Weersma Rinse K.,van Goor Harry,Mann Giovanni E.,Dijkstra Gerard,Faber Klaas N.

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference100 articles.

1. Epidemiology of inflammatory bowel diseases: a population study in a healthcare district of North-West Italy;Caviglia;J. Clin. Med.,2023

2. Inflammatory bowel disease pathogenesis: where are we?;Fiocchi;J. Gastroenterol. Hepatol.,2015

3. International Consortium for Therapeutic Drug Monitoring. Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives;Papamichael;Lancet Gastroenterol. Hepatol.,2022

4. Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets;Bourgonje;Redox Biol.,2023

5. Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease;Bourgonje;Trends Mol. Med.,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bufalin alleviates inflammatory response and oxidative stress in experimental severe acute pancreatitis through activating Keap1-Nrf2/HO-1 and inhibiting NF-κB pathways;International Immunopharmacology;2024-12

2. Chitosan oligosaccharides alleviate macrophage pyroptosis and protect sepsis mice via activating the Nrf2/GPX4 pathway;International Journal of Biological Macromolecules;2024-10

3. Lactiplantibacillus plantarum JM113 alleviates deoxynivalenol induced intestinal damage by microbial modulation in broiler chickens;Poultry Science;2024-09

4. Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease;Antioxidants;2024-08-20

5. Hydrogel-forming viscous liquid in response to ROS restores the gut mucosal barrier of colitis mice via regulating oxidative redox homeostasis;Acta Biomaterialia;2024-08